Sangamo Therapeutics, Inc. SGMO 深 滬
等待開盤 02-06 09:30:00 美东时间
0.3535
-0.007
-1.86%
華盛通- 最 高0.3839
- 今 開0.3607
- 成交量 894.12万股
- 最 低 0.345
- 昨 收 0.3602
- 總市值 1.19亿
- 52周最高 1.2383
- 市盈率 靜 --
- 換手率 2.66%
- 52周最低 0.345
- 委 比 -94.77%
- 總股本 3.36亿
- 歷史最高 27.50
- 量 比 0.48
- 振 幅 10.80%
- 歷史最低 0.2911
- 每 手 1
- 風險率 0.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sangamo Biosciences launches dilutive February 2026 financing
An update from Sangamo Biosciences ( ($SGMO) ) is now available. On February 3,...
02-04 21:59
Sangamo Therapeutics stellt positive Phase-1/2-Studienergebnisse für Gentherapie bei Fabry-Krankheit vor
Sangamo Therapeutics stellt positive Phase-1/2-Studienergebnisse für Gentherapie bei Fabry-Krankheit vor Sangamo Therapeutics Inc. hat am 3. Februar 2026 die Präsentation klinischer Daten aus der zulassungsrelevanten Phase-1/2-STAAR-Studie zu Isaralgagene Civaparvovec (ST-920), einem firmeneigenen G
02-04 05:09
FDA prüft Zulassungsantrag für Sangamos Gentherapie bei Fabry-Krankheit
FDA prüft Zulassungsantrag für Sangamos Gentherapie bei Fabry-Krankheit Sangamo Therapeutics Inc. hat mit der rollierenden Einreichung eines Biologics License Application (BLA) bei der US-amerikanischen Food and Drug Administration (FDA) im Rahmen des Accelerated Approval Programms für das Gentherap
02-04 05:08
BUZZ-U.S. STOCKS ON THE MOVE-Western Digital, Broadridge, WTW
BUZZ-U.S. STOCKS ON THE MOVE-Western Digital, Broadridge, WTW Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose on Tuesday as Palantir's results aided o
02-04 00:02
BUZZ-Sangamo Therapeutics slides after $25 million stock sale
BUZZ-Sangamo Therapeutics slides after $25 million stock sale ** Shares of genomic medicine firm Sangamo Therapeutics SGMO.O slide 19% to $0.46 premarket ** SGMO announces pricing of $25 million stock sale at $0.4719 apiece ** Company sold 35.2 million shares and pre-funded warrants to purchase 17.8
02-03 22:27
Sangamo Prices Underwritten Offering Of 35.2M Common Shares And Pre‑Funded Warrants For 17.8M Shares, Together With Warrants To Purchase 53.0M Shares At Combined Offering Price Of $0.4719 Per Share And Warrant
RICHMOND, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced the pricing of an underwritten offering consisting of 35,190,292 shares of its
02-03 22:15
BRIEF-Sangamo Therapeutics Inc - On Feb 2, Prathyusha Duraibabu Terminated As Principal Financial Officer - SEC Filing
BRIEF-Sangamo Therapeutics Inc - On Feb 2, Prathyusha Duraibabu Terminated As Principal Financial Officer - SEC Filing Feb 3 (Reuters) - Sangamo Therapeutics Inc SGMO.O : SANGAMO THERAPEUTICS INC - ON FEB 2, PRATHYUSHA DURAIBABU TERMINATED AS PRINCIPAL FINANCIAL OFFICER - SEC FILING SANGAMO THERAPEU
02-03 22:03
Sangamo Therapeutics Appoints Nikunj Jain as Interim CFO
Sangamo Therapeutics Appoints Nikunj Jain as Interim CFO Sangamo Therapeutics Inc. announced that Prathyusha Duraibabu has left her role as principal financial officer. Nikunj Jain, previously Vice President, Finance and Corporate Controller, has been appointed Interim Chief Financial Officer and wi
02-03 21:56
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering
<p><p>RICHMOND, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced the pricing of an underwritten offering, including 35,190,292 shares of common stock, pre-funded warrants for 17,787,033 shares, and accompanying warrants for 52,977,325 shares. The combined offering price per share and accompanying warrant is $0.4719, while the pre-funded warrant and accompanying warrant combination is priced at $0.4619....
02-03 14:10
美股牛股 | 矽晶电信飙升近30%，Q4营收同比大增17%；西南航空大涨18%
矽晶电信飙升近30%，Q4营收同比大增17%；摩丁制造大涨20%，分拆技术业务并与Gentherm合并，以优化公司结构；西南航空大涨18%，Q4每股收益及全年指引均超预期>>
01-30 18:27
